StonvexLoading…
StonvexCore line items from CAPR's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Q3 2024 2024-09-30 | Q2 2024 2024-06-30 |
|---|---|---|---|---|
Revenue | $0.00 | $22.27M | $11.14M | $8.88M |
Operating Income | $-108.14M | $-42.56M | $-34.87M | $-21.86M |
Net Income | $-105.04M | $-40.47M | $-33.35M | $-11.00M |
EPS (Diluted) | $-2.26 | $-1.15 | $-1.04 | $-0.66 |
Total Assets | $355.95M | $170.48M | $92.95M | $38.28M |
Total Liabilities | $50.16M | $25.02M | $24.69M | $26.78M |
Cash & Equivalents | $287.85M | $11.29M | $68.38M | $10.69M |
Free Cash Flow OCF − CapEx | $-72.72M | $-41.16M | $-25.88M | $-14.23M |
Shares Outstanding | 57.37M | 45.58M | 40.33M | 31.98M |